SNCA and Parkinson disease: We recently described a Drosophila model relevant to Parkinson’s disease and related α-synucleinopathies in which human wild-type α-synuclein is expressed using the QF2 bipartite expression system14 and the nSyb-QF2 pan-neuronal driver.